Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.460
-0.120 (-7.59%)
At close: Oct 23, 2026, 4:00 PM EDT
1.500
+0.040 (2.74%)
After-hours: Oct 23, 2026, 7:07 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $264.37 million as of October 23, 2026. It is the 18,941st most valuable company in the world and the 3,313th biggest in the United States. Its market cap has increased by 443.56% in one year.
Market Cap
264.37M
Enterprise Value
183.32M
1-Year Change
443.56%
Global Rank
Country Rank
#3,313 United States
Category
ChartMarket Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $264.37M, a decrease of -74.85%. That is a compound annual growth rate of -22.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 264.37M | 204.37% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 309.13M |
| Turn Therapeutics | 306.22M |
| Inhibikase Therapeutics | 301.33M |
| X4 Pharmaceuticals | 297.44M |
| Benitec Biopharma | 296.50M |
| Surrozen | 295.95M |
| Agenus | 288.58M |
| Fulcrum Therapeutics | 283.83M |